ASS-ratiopharm® 100 mg TAH Tabletten, Xarelto 15 mg film-coated tablets
OHIRC-20150866
Approved small_molecule active
Quick answer
ASS-ratiopharm® 100 mg TAH Tabletten, Xarelto 15 mg film-coated tablets for Risk of stroke by Atrial Fibrillation is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Risk of stroke by Atrial Fibrillation
- Phase
- Approved
- Modality
- small_molecule
- Status
- active